AIM
DGX icon

Allstate Investment Management’s Quest Diagnostics DGX Stock Holding History

Allstate Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$688K Buy
+4,398
New +$632K 0.02% 434

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Allstate Investment Management's DGX Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Quest Diagnostics (DGX) in Q4 2022: 4,398 shares worth $688K. The stake represents 0.02% of the portfolio and ranks #434 among its holdings.

878 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Allstate Investment Management held 4,398 shares of Quest Diagnostics worth $688K as of Q4 2022.
  • Quest Diagnostics was a new Allstate Investment Management position in Q4 2022.
  • Quest Diagnostics made up 0.02% of Allstate Investment Management's portfolio in Q4 2022, its #434 holding.
  • 878 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.